Biological Indicators Industry Research Report 2024
Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.
According to APO Research, The global Biological Indicators market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Biological Indicators main players are 3M, Getinge Group, Cantel Medical, Mesa Laboratories, Steris, etc. Global top five manufacturers hold a share over 65%. North America is the largest market, with a share nearly 55%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biological Indicators, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biological Indicators.
The Biological Indicators market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biological Indicators market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biological Indicators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biological Indicators and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biological Indicators.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Biological Indicators companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Chapter 13: The main points and conclusions of the report.
According to APO Research, The global Biological Indicators market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Biological Indicators main players are 3M, Getinge Group, Cantel Medical, Mesa Laboratories, Steris, etc. Global top five manufacturers hold a share over 65%. North America is the largest market, with a share nearly 55%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biological Indicators, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biological Indicators.
The Biological Indicators market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biological Indicators market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- 3M
- Getinge Group
- Cantel Medical
- Mesa Laboratories
- Steris
- Fuze Medical
- Matachana
- Hu-Friedy
- Advanced Sterilization
- Bag Health Care
- Terragene
- Andersen
- GKE
- Self-Contained Biological Indicator
- Biological Indicator Strip
- Hospital
- Pharma Companies
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biological Indicators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biological Indicators and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biological Indicators.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Biological Indicators companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Biological Indicators by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Self-Contained Biological Indicator
2.2.3 Biological Indicator Strip
2.3 Biological Indicators by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Hospital
2.3.3 Pharma Companies
2.3.4 Others
2.4 Assumptions and Limitations
3 BIOLOGICAL INDICATORS BREAKDOWN DATA BY TYPE
3.1 Global Biological Indicators Historic Market Size by Type (2019-2024)
3.2 Global Biological Indicators Forecasted Market Size by Type (2025-2030)
4 BIOLOGICAL INDICATORS BREAKDOWN DATA BY APPLICATION
4.1 Global Biological Indicators Historic Market Size by Application (2019-2024)
4.2 Global Biological Indicators Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Biological Indicators Market Perspective (2019-2030)
5.2 Global Biological Indicators Growth Trends by Region
5.2.1 Global Biological Indicators Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Biological Indicators Historic Market Size by Region (2019-2024)
5.2.3 Biological Indicators Forecasted Market Size by Region (2025-2030)
5.3 Biological Indicators Market Dynamics
5.3.1 Biological Indicators Industry Trends
5.3.2 Biological Indicators Market Drivers
5.3.3 Biological Indicators Market Challenges
5.3.4 Biological Indicators Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Biological Indicators Players by Revenue
6.1.1 Global Top Biological Indicators Players by Revenue (2019-2024)
6.1.2 Global Biological Indicators Revenue Market Share by Players (2019-2024)
6.2 Global Biological Indicators Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Biological Indicators Head office and Area Served
6.4 Global Biological Indicators Players, Product Type & Application
6.5 Global Biological Indicators Players, Date of Enter into This Industry
6.6 Global Biological Indicators Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Biological Indicators Market Size (2019-2030)
7.2 North America Biological Indicators Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Biological Indicators Market Size by Country (2019-2024)
7.4 North America Biological Indicators Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Biological Indicators Market Size (2019-2030)
8.2 Europe Biological Indicators Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Biological Indicators Market Size by Country (2019-2024)
8.4 Europe Biological Indicators Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Biological Indicators Market Size (2019-2030)
9.2 Asia-Pacific Biological Indicators Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Biological Indicators Market Size by Country (2019-2024)
9.4 Asia-Pacific Biological Indicators Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Biological Indicators Market Size (2019-2030)
10.2 Latin America Biological Indicators Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Biological Indicators Market Size by Country (2019-2024)
10.4 Latin America Biological Indicators Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Biological Indicators Market Size (2019-2030)
11.2 Middle East & Africa Biological Indicators Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Biological Indicators Market Size by Country (2019-2024)
11.4 Middle East & Africa Biological Indicators Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 3M
12.1.1 3M Company Information
12.1.2 3M Business Overview
12.1.3 3M Revenue in Biological Indicators Business (2019-2024)
12.1.4 3M Biological Indicators Product Portfolio
12.1.5 3M Recent Developments
12.2 Getinge Group
12.2.1 Getinge Group Company Information
12.2.2 Getinge Group Business Overview
12.2.3 Getinge Group Revenue in Biological Indicators Business (2019-2024)
12.2.4 Getinge Group Biological Indicators Product Portfolio
12.2.5 Getinge Group Recent Developments
12.3 Cantel Medical
12.3.1 Cantel Medical Company Information
12.3.2 Cantel Medical Business Overview
12.3.3 Cantel Medical Revenue in Biological Indicators Business (2019-2024)
12.3.4 Cantel Medical Biological Indicators Product Portfolio
12.3.5 Cantel Medical Recent Developments
12.4 Mesa Laboratories
12.4.1 Mesa Laboratories Company Information
12.4.2 Mesa Laboratories Business Overview
12.4.3 Mesa Laboratories Revenue in Biological Indicators Business (2019-2024)
12.4.4 Mesa Laboratories Biological Indicators Product Portfolio
12.4.5 Mesa Laboratories Recent Developments
12.5 Steris
12.5.1 Steris Company Information
12.5.2 Steris Business Overview
12.5.3 Steris Revenue in Biological Indicators Business (2019-2024)
12.5.4 Steris Biological Indicators Product Portfolio
12.5.5 Steris Recent Developments
12.6 Fuze Medical
12.6.1 Fuze Medical Company Information
12.6.2 Fuze Medical Business Overview
12.6.3 Fuze Medical Revenue in Biological Indicators Business (2019-2024)
12.6.4 Fuze Medical Biological Indicators Product Portfolio
12.6.5 Fuze Medical Recent Developments
12.7 Matachana
12.7.1 Matachana Company Information
12.7.2 Matachana Business Overview
12.7.3 Matachana Revenue in Biological Indicators Business (2019-2024)
12.7.4 Matachana Biological Indicators Product Portfolio
12.7.5 Matachana Recent Developments
12.8 Hu-Friedy
12.8.1 Hu-Friedy Company Information
12.8.2 Hu-Friedy Business Overview
12.8.3 Hu-Friedy Revenue in Biological Indicators Business (2019-2024)
12.8.4 Hu-Friedy Biological Indicators Product Portfolio
12.8.5 Hu-Friedy Recent Developments
12.9 Advanced Sterilization
12.9.1 Advanced Sterilization Company Information
12.9.2 Advanced Sterilization Business Overview
12.9.3 Advanced Sterilization Revenue in Biological Indicators Business (2019-2024)
12.9.4 Advanced Sterilization Biological Indicators Product Portfolio
12.9.5 Advanced Sterilization Recent Developments
12.10 Bag Health Care
12.10.1 Bag Health Care Company Information
12.10.2 Bag Health Care Business Overview
12.10.3 Bag Health Care Revenue in Biological Indicators Business (2019-2024)
12.10.4 Bag Health Care Biological Indicators Product Portfolio
12.10.5 Bag Health Care Recent Developments
12.11 Terragene
12.11.1 Terragene Company Information
12.11.2 Terragene Business Overview
12.11.3 Terragene Revenue in Biological Indicators Business (2019-2024)
12.11.4 Terragene Biological Indicators Product Portfolio
12.11.5 Terragene Recent Developments
12.12 Andersen
12.12.1 Andersen Company Information
12.12.2 Andersen Business Overview
12.12.3 Andersen Revenue in Biological Indicators Business (2019-2024)
12.12.4 Andersen Biological Indicators Product Portfolio
12.12.5 Andersen Recent Developments
12.13 GKE
12.13.1 GKE Company Information
12.13.2 GKE Business Overview
12.13.3 GKE Revenue in Biological Indicators Business (2019-2024)
12.13.4 GKE Biological Indicators Product Portfolio
12.13.5 GKE Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Biological Indicators by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Self-Contained Biological Indicator
2.2.3 Biological Indicator Strip
2.3 Biological Indicators by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Hospital
2.3.3 Pharma Companies
2.3.4 Others
2.4 Assumptions and Limitations
3 BIOLOGICAL INDICATORS BREAKDOWN DATA BY TYPE
3.1 Global Biological Indicators Historic Market Size by Type (2019-2024)
3.2 Global Biological Indicators Forecasted Market Size by Type (2025-2030)
4 BIOLOGICAL INDICATORS BREAKDOWN DATA BY APPLICATION
4.1 Global Biological Indicators Historic Market Size by Application (2019-2024)
4.2 Global Biological Indicators Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Biological Indicators Market Perspective (2019-2030)
5.2 Global Biological Indicators Growth Trends by Region
5.2.1 Global Biological Indicators Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Biological Indicators Historic Market Size by Region (2019-2024)
5.2.3 Biological Indicators Forecasted Market Size by Region (2025-2030)
5.3 Biological Indicators Market Dynamics
5.3.1 Biological Indicators Industry Trends
5.3.2 Biological Indicators Market Drivers
5.3.3 Biological Indicators Market Challenges
5.3.4 Biological Indicators Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Biological Indicators Players by Revenue
6.1.1 Global Top Biological Indicators Players by Revenue (2019-2024)
6.1.2 Global Biological Indicators Revenue Market Share by Players (2019-2024)
6.2 Global Biological Indicators Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Biological Indicators Head office and Area Served
6.4 Global Biological Indicators Players, Product Type & Application
6.5 Global Biological Indicators Players, Date of Enter into This Industry
6.6 Global Biological Indicators Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Biological Indicators Market Size (2019-2030)
7.2 North America Biological Indicators Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Biological Indicators Market Size by Country (2019-2024)
7.4 North America Biological Indicators Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Biological Indicators Market Size (2019-2030)
8.2 Europe Biological Indicators Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Biological Indicators Market Size by Country (2019-2024)
8.4 Europe Biological Indicators Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Biological Indicators Market Size (2019-2030)
9.2 Asia-Pacific Biological Indicators Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Biological Indicators Market Size by Country (2019-2024)
9.4 Asia-Pacific Biological Indicators Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Biological Indicators Market Size (2019-2030)
10.2 Latin America Biological Indicators Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Biological Indicators Market Size by Country (2019-2024)
10.4 Latin America Biological Indicators Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Biological Indicators Market Size (2019-2030)
11.2 Middle East & Africa Biological Indicators Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Biological Indicators Market Size by Country (2019-2024)
11.4 Middle East & Africa Biological Indicators Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 3M
12.1.1 3M Company Information
12.1.2 3M Business Overview
12.1.3 3M Revenue in Biological Indicators Business (2019-2024)
12.1.4 3M Biological Indicators Product Portfolio
12.1.5 3M Recent Developments
12.2 Getinge Group
12.2.1 Getinge Group Company Information
12.2.2 Getinge Group Business Overview
12.2.3 Getinge Group Revenue in Biological Indicators Business (2019-2024)
12.2.4 Getinge Group Biological Indicators Product Portfolio
12.2.5 Getinge Group Recent Developments
12.3 Cantel Medical
12.3.1 Cantel Medical Company Information
12.3.2 Cantel Medical Business Overview
12.3.3 Cantel Medical Revenue in Biological Indicators Business (2019-2024)
12.3.4 Cantel Medical Biological Indicators Product Portfolio
12.3.5 Cantel Medical Recent Developments
12.4 Mesa Laboratories
12.4.1 Mesa Laboratories Company Information
12.4.2 Mesa Laboratories Business Overview
12.4.3 Mesa Laboratories Revenue in Biological Indicators Business (2019-2024)
12.4.4 Mesa Laboratories Biological Indicators Product Portfolio
12.4.5 Mesa Laboratories Recent Developments
12.5 Steris
12.5.1 Steris Company Information
12.5.2 Steris Business Overview
12.5.3 Steris Revenue in Biological Indicators Business (2019-2024)
12.5.4 Steris Biological Indicators Product Portfolio
12.5.5 Steris Recent Developments
12.6 Fuze Medical
12.6.1 Fuze Medical Company Information
12.6.2 Fuze Medical Business Overview
12.6.3 Fuze Medical Revenue in Biological Indicators Business (2019-2024)
12.6.4 Fuze Medical Biological Indicators Product Portfolio
12.6.5 Fuze Medical Recent Developments
12.7 Matachana
12.7.1 Matachana Company Information
12.7.2 Matachana Business Overview
12.7.3 Matachana Revenue in Biological Indicators Business (2019-2024)
12.7.4 Matachana Biological Indicators Product Portfolio
12.7.5 Matachana Recent Developments
12.8 Hu-Friedy
12.8.1 Hu-Friedy Company Information
12.8.2 Hu-Friedy Business Overview
12.8.3 Hu-Friedy Revenue in Biological Indicators Business (2019-2024)
12.8.4 Hu-Friedy Biological Indicators Product Portfolio
12.8.5 Hu-Friedy Recent Developments
12.9 Advanced Sterilization
12.9.1 Advanced Sterilization Company Information
12.9.2 Advanced Sterilization Business Overview
12.9.3 Advanced Sterilization Revenue in Biological Indicators Business (2019-2024)
12.9.4 Advanced Sterilization Biological Indicators Product Portfolio
12.9.5 Advanced Sterilization Recent Developments
12.10 Bag Health Care
12.10.1 Bag Health Care Company Information
12.10.2 Bag Health Care Business Overview
12.10.3 Bag Health Care Revenue in Biological Indicators Business (2019-2024)
12.10.4 Bag Health Care Biological Indicators Product Portfolio
12.10.5 Bag Health Care Recent Developments
12.11 Terragene
12.11.1 Terragene Company Information
12.11.2 Terragene Business Overview
12.11.3 Terragene Revenue in Biological Indicators Business (2019-2024)
12.11.4 Terragene Biological Indicators Product Portfolio
12.11.5 Terragene Recent Developments
12.12 Andersen
12.12.1 Andersen Company Information
12.12.2 Andersen Business Overview
12.12.3 Andersen Revenue in Biological Indicators Business (2019-2024)
12.12.4 Andersen Biological Indicators Product Portfolio
12.12.5 Andersen Recent Developments
12.13 GKE
12.13.1 GKE Company Information
12.13.2 GKE Business Overview
12.13.3 GKE Revenue in Biological Indicators Business (2019-2024)
12.13.4 GKE Biological Indicators Product Portfolio
12.13.5 GKE Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
